Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aurora SpineASAPF 38 Operating Cash Flow per Share is $0.01 as of Mar. 2026. GuruFocus rates ASAPF with a GF Score™ of 38/100 and a GF Value™ of $0.25 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 650 Medical Devices & Instruments companies, Aurora Spine ranks worse than 153846% on this metric.
Aurora Spine's operating cash flow per share for the
three
months ended in Mar. 2026 was $0.00.
Aurora Spine's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.01.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Aurora Spine's Operating Cash Flow per Share or its related term are showing as below:
During the past 13 years, Aurora Spine's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.00% per year. The lowest was 30.60% per year. And the median was 41.30% per year.
ASAPF's 3-Year OCF Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 12.2 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Aurora Spine Operating Cash Flow per Share Related Terms
Aurora Spine Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Aurora Spine's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASAPF vs ABT, SYK, MDT: Operating Cash Flow per Share Comparison
For the Medical Devices subindustry, Aurora Spine's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Spine Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Aurora Spine's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $0.01 mean?
Aurora Spine (ASAPF) has a Operating Cash Flow per Share of $0.01 as of Mar. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Aurora Spine and its competitors. According to the industry distribution chart, Aurora Spine ranks #999999 out of 650 companies in the Medical Devices & Instruments industry.
Is Aurora Spine's Operating Cash Flow per Share too high?
Aurora Spine's current Operating Cash Flow per Share is $0.01. The Medical Devices & Instruments industry median Operating Cash Flow per Share is 12.20. Aurora Spine's value of $0.01 is 99.9% below this industry median. Based on the distribution chart, Aurora Spine ranks #999999 out of 650 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Aurora Spine has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Operating Cash Flow per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aurora Spine ranks #999999 out of 650 companies for Operating Cash Flow per Share. This places Aurora Spine in the lower half of its industry. The industry median Operating Cash Flow per Share is 12.20. Aurora Spine's value of $0.01 is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.20, based on 650 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurora Spine's current Operating Cash Flow per Share of $0.01 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Aurora Spine and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Spine's current Operating Cash Flow per Share is $0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.25, compared to a current price of $0.17 — trading 33.6% below its estimated fair value. The current Operating Cash Flow per Share is $0.01 and 99.9% below the Medical Devices & Instruments industry median of 12.20. Aurora Spine's overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Operating Cash Flow per Share is $0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Spine (ASAPF) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued.
The current stock price of $0.17 is trading 33.6% below its estimated GF Value™ of $0.25.
GuruFocus considers Aurora Spine to be Possible Value Trap.
Key valuation signals for ASAPF:
Operating Cash Flow per Share: $0.01
GF Value™: $0.25 vs. price of $0.17 (33.6% below fair value)
Industry Position: 99.9% below the Medical Devices & Instruments median (#999999 of 650)
No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
38GF Score
Get the complete analysis for ASAPF
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASAPF has been successfully added to your 
